Eli Lilly signs a global licensing deal with Rznomics to co-develop RNA-editing therapies for hearing loss, with potential ...

This partnership, which officials said has the potential to be the largest ever U.S. industry-academic agreement of its kind, ...

Rznomics Inc., a South Korea-based biopharmaceutical company specializing in RNA-based therapeutics, has entered into a ...

collaboration with AdvanCell to advance novel targeted alpha therapies for the treatment of cancer; and Chugai Pharmaceutical Co., Ltd. Eli Lilly and Company was founded in 1876 and is ...

INDIANAPOLIS — Indianapolis-based pharmaceutical giant Eli Lilly and Company will ... company and the largest university expand collaboration at a scale never seen before, especially in the backdrop ...

Eli Lilly (NYSE:LLY) reported its Q1 2025 earnings ... It has been able to establish that collaboration agreement I noted above with Septerna to develop oral small molecule G-Coupled Protein ...

Looking for undervalued stocks? Check out three top undervalued stocks to buy now in May, 2025 to boost your portfolio.

INDIANAPOLIS and WEST LAFAYETTE, May 9, 2025 — Eli Lilly and Company (NYSE: LLY) and Purdue University announced today a significant expansion of their long-standing alliance, with Lilly’s planned ...

Eli Lilly and Company and Purdue University announced a significant expansion of their long-standing alliance, with Lilly's planned investment of up to $250 million in the collaboration over the next ...

Eli Lilly and Co. and Purdue University announced today a significant expansion of their long-standing alliance, with Lilly’s planned investment of up to $250 million in the collaboration over ...

May 9, 2025 /PRNewswire/ -- Eli Lilly and Company ... of their long-standing alliance, with Lilly's planned investment of up to $250 million in the collaboration over the next eight years.